Men diagnosed at this hospital trust can access the following services:

• Treatment Facilities:
• External beam radiotherapy (EBRT)
• High-dose rate brachytherapy
• HIFU

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	110	1394
Performance Status recorded	7%	40%
PSA completed	72%	48%
Gleason Score completed	72%	77%
TNM completed	61%	72%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men with disease status determined	1276	39897
Percentage of men diagnosed with metastatic disease	16%	17%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	229	4684
Percentage of men with low-risk localised disease receiving radical treatment	8%	8%
No. of men diagnosed with locally advanced disease	504	15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment	65%	68%

	Treatment Centre
No. of men who received radical radiotherapy ()	179
Adjusted percentage of men experiencing at least one GI complication (%)	8%